CEO360 Cohorts
Specialized Pathways.
Shared Discipline.
CEO360 cohorts are organized by
technology modality, allowing CEOs to work alongside
peers facing similar scientific, regulatory, and capital challenges.
Each cohort is supported by industry partners,
venture investors, and ecosystem leaders who help translate
innovation into investable companies.
CEO360 Cohorts
CEO360
Innovation Cohorts
From IND Path to Investable Company
Designed for CEOs developing small molecule therapeutics navigating early clinical, regulatory, and capital formation milestones.
Focus areas include:
• Translational strategy and POC clarity
• IND readiness and regulatory planning
• Capital efficiency and milestone design
• Investor narrative development
Biologics Innovation to Capital Investment
Built for CEOs leading antibody, protein, and biologics platforms navigating complex development and manufacturing paths.
Focus areas include:
• Platform vs asset strategy clarity
• Regulatory and development sequencing
• Manufacturing and scale readiness
• Investor diligence preparation
Device Innovation to Market Adoption
Designed for medical device, diagnostics, and biological tools CEOs moving from validation toward commercialization and capital readiness.
Focus areas include:
• Clinical and regulatory pathways
• Reimbursement and adoption strategy
• Manufacturing scale planning
• Investor readiness